# Perioperative Treatment of Metachronous Multiple Lung Cancer with Organizing Pneumonia: A Case Report

**Authors:** Hiroshi Takehara, Ken Kodama, Toru Momozane, Kansuke Kido

PMC · DOI: 10.5761/atcs.cr.25-00089 · Annals of Thoracic and Cardiovascular Surgery · 2025-08-14

## TL;DR

A 67-year-old man with lung cancer and organizing pneumonia in different lung lobes was successfully managed with surgery and corticosteroids, showing the importance of tailored treatment.

## Contribution

This case report presents a rare coexistence of lung cancer and organizing pneumonia and demonstrates an individualized perioperative management approach.

## Key findings

- Surgical resection and corticosteroid therapy effectively managed coexisting lung cancer and organizing pneumonia.
- Postoperative macrolide therapy for 3 months prevented OP recurrence for 14 months.
- Bone metastases responded well to chemoradiotherapy after initial treatment.

## Abstract

We report a rare case of the independent coexistence of lung cancer and organizing pneumonia (OP) in different lobes of the right lung in a 67-year-old man with a history of left upper lobectomy. Computed tomography revealed a lesion consistent with OP in the right upper lobe and a suspicious shadow in the right lower lobe, which was diagnosed as squamous cell carcinoma via bronchoscopic biopsy. The patient underwent right lower lobectomy and partial resection of the right upper lobe under left one-lung ventilation. Empirical corticosteroids were administered preoperatively, followed by a brief postoperative course for 3 days after pathological confirmation of OP to reduce complications such as bronchial fistula, then transitioned to macrolide therapy for 3 months. Fourteen months postoperatively, OP had not recurred, although bone metastases developed and responded well to chemoradiotherapy. This case highlights the need for individualized perioperative management in patients with complex pulmonary pathology.

## Linked entities

- **Diseases:** lung cancer (MONDO:0005138), organizing pneumonia (MONDO:0015264)

## Full-text entities

- **Genes:** KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, CALM3 (calmodulin 3) [NCBI Gene 808] {aka CALM, CAM1, CAM2, CAMB, CPVT6, CaM}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** Pneumonia (MESH:D011014), Coronavirus disease 2019 (MESH:D000086382), Lipoid pneumonia (MESH:D011017), autoimmune disease (MESH:D001327), bone metastases (MESH:D009362), lymphadenopathy (MESH:D008206), Tumor necrosis (MESH:D009369), stenosis (MESH:D003251), IIB (MESH:C536043), diabetes mellitus (MESH:D003920), dyspnea (MESH:D004417), pulmonary artery embolism (MESH:D011655), Lung Cancer (MESH:D008175), bronchiolitis obliterans organizing pneumonia (MESH:D018549), MB-LL (OMIM:613675), OP (MESH:D000092124), inflammation (MESH:D007249), chest trauma (MESH:D013898), necrosis (MESH:D009336), lesion (MESH:D009059), bronchial fistula (MESH:D001983), fever (MESH:D005334), febrile (MESH:D000071072), T-MB (MESH:D001260), lung squamous cell carcinoma (MESH:D002294)
- **Chemicals:** carboplatin (MESH:D016190), meropenem (MESH:D000077731), paclitaxel (MESH:D017239), pembrolizumab (MESH:C582435), macrolide (MESH:D018942), H-E (MESH:D006371), oxygen (MESH:D010100), Aspergillus galactomannan (-), clarithromycin (MESH:D017291), PS (MESH:D010758), eosin (MESH:D004801), steroid (MESH:D013256), levofloxacin (MESH:D064704), methylprednisolone (MESH:D008775), prednisolone (MESH:D011239), hematoxylin (MESH:D006416)
- **Species:** Mycobacterium avium complex sp. (species) [taxon 37162], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12352969/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12352969/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12352969/full.md

---
Source: https://tomesphere.com/paper/PMC12352969